Ligands for Target Protein for PROTAC

PROTAC 分子由靶蛋白配体和 E3 泛素连接酶配体组成,并通过连接子将它们结合在一起。靶蛋白的配体将导致 PROTAC 附着到目标蛋白上进行泛素化并随后降解。

靶蛋白通常是其过表达或积累可能在疾病进展中发挥重要作用的蛋白质。许多 PROTAC 已被开发用于降解激酶(例如 MEK、KRAS、CDK 和 Bcr/Abl)、转录因子(例如 p53、STAT、RAR、ER 和 AR)、表观遗传工具(例如 HDAC 和 BET 溴结构域)和 E3 连接酶本身(例如 MDM2)。

The PROTAC molecule consists of a target protein ligand and an E3 ubiquitin ligase ligand, with a linker binds them together. The ligand for target protein will lead to attachment of a PROTAC to the proteins of interest for ubiquitin and subsequent degradation.

Target proteins are usually proteins whose overexpression or accumulation may play important roles in the progress of diseases. Numbers of PROTACs have been developed to degrade kinases (such as MEK, KRAS, CDK and Bcr/Abl), transcription factors (such as p53, STAT, RAR, ER and AR), epigenetic tools (such as HDAC and BET bromodomain) and E3 ligase themselves (such as MDM2).

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
BCL-xL ligand 2

BCL-xL ligand 2 是一种 BCL-xL 配体,可与 E3 连接酶配体 (MS-B84852) 及 linker 偶联,用于合成靶向降解 Bcl-xL 的 PROTAC 降解剂 PZ671 (MS-Q19540)。

Degrader
BCL-xL ligand 2

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础